1. Home
  2. FFIC vs ALT Comparison

FFIC vs ALT Comparison

Compare FFIC & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFIC
  • ALT
  • Stock Information
  • Founded
  • FFIC 1929
  • ALT 1997
  • Country
  • FFIC United States
  • ALT United States
  • Employees
  • FFIC N/A
  • ALT N/A
  • Industry
  • FFIC Major Banks
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FFIC Finance
  • ALT Health Care
  • Exchange
  • FFIC Nasdaq
  • ALT Nasdaq
  • Market Cap
  • FFIC 415.1M
  • ALT 472.3M
  • IPO Year
  • FFIC 1995
  • ALT N/A
  • Fundamental
  • Price
  • FFIC $11.93
  • ALT $7.19
  • Analyst Decision
  • FFIC Hold
  • ALT Strong Buy
  • Analyst Count
  • FFIC 3
  • ALT 7
  • Target Price
  • FFIC $16.17
  • ALT $21.00
  • AVG Volume (30 Days)
  • FFIC 175.4K
  • ALT 4.1M
  • Earning Date
  • FFIC 07-24-2025
  • ALT 08-07-2025
  • Dividend Yield
  • FFIC 7.44%
  • ALT N/A
  • EPS Growth
  • FFIC N/A
  • ALT N/A
  • EPS
  • FFIC N/A
  • ALT N/A
  • Revenue
  • FFIC $124,028,000.00
  • ALT $20,000.00
  • Revenue This Year
  • FFIC $112.30
  • ALT N/A
  • Revenue Next Year
  • FFIC $7.61
  • ALT $1,557,547.90
  • P/E Ratio
  • FFIC N/A
  • ALT N/A
  • Revenue Growth
  • FFIC N/A
  • ALT N/A
  • 52 Week Low
  • FFIC $10.65
  • ALT $3.55
  • 52 Week High
  • FFIC $18.59
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • FFIC 48.63
  • ALT 68.14
  • Support Level
  • FFIC $11.13
  • ALT $6.61
  • Resistance Level
  • FFIC $12.49
  • ALT $7.52
  • Average True Range (ATR)
  • FFIC 0.29
  • ALT 0.54
  • MACD
  • FFIC -0.01
  • ALT 0.08
  • Stochastic Oscillator
  • FFIC 58.82
  • ALT 84.90

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: